Skip to content
Jamie L. Wooldridge, M.D.

Jamie L. Wooldridge, M.D.

Pediatrics, Pediatric Pulmonology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

About Me

Professional Background

Dr. Wooldridge has a passion for taking care of kids with asthma. Both in taking care of kids with asthma and improving asthma care in the community. Dr. Wooldridge utilizes motivation interviewing in working with patients and their caregivers to identify changes they can make to improve their asthm...
Dr. Wooldridge has a passion for taking care of kids with asthma. Both in taking care of kids with asthma and improving asthma care in the community. Dr. Wooldridge utilizes motivation interviewing in working with patients and their caregivers to identify changes they can make to improve their asthma symptoms. She also has a number of tools to help patients understand asthma and improve adherence with their medications. She is the pulmonologist for the Severe Asthma Clinic at Golisano Children’s Hospital.

Dr. Wooldridge is one of four physician champions for the NYS Asthma Control Program which is funded by the CDC to reduce asthma ED visits and admissions across the state of New York. This work includes working with hospitals and primary care practices to implement a care processes ensuring patients receive guideline-based asthma care including education and self-management tools.

Dr. Wooldridge received her M.D. from Indiana University, completed her pediatric residency training at Riley Children’s Hospital, Indianapolis, and her pediatric pulmonary fellowship at University of Colorado Health Sciences Center. She was faculty at Cincinnati Children’s Hospital Medical Center from 2002 through 2010 where she utilized quality improvement methods to improve care of children with Cystic Fibrosis. She moved to St. Louis University School of Medicine and Cardinal Glennon Children’s Medical Center in 2010 where she led the quality improvement teams in asthma and cystic fibrosis. From 2016 to 2020, she was the Chief of Division of Pediatric Pulmonology, Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo. In the position, she started the first dedicated pediatric sleep program in Buffalo, recruited faculty to develop a center of excellence for technology dependent patients, and initiated an asthma population health initiative. In 2020, she moved to University of Rochester Medical Center where she continues a population health initiative.

She is currently working on a Masters in Population Health through Thomas Jefferson University to improve her work on improving asthma outcomes and value based payment contracts. She has been the principal investigator for numerous clinical research trials. She is the author/co-author of over 20 scientific articles and book chapters.

Certified Specialties

Pediatric Pulmonology - American Board of Pediatrics

Faculty Appointments

Professor of Clinical Pediatrics - Department of Pediatrics (SMD)

Credentials

Residency & Fellowship

Fellowship, Fellow, University Of Colorado At Denver. 1998 - 2002

Internship, Pediatrics, Riley Hospital for Children. 1995 - 1996

Residency, Resident, Riley Hospital for Children. 1995 - 1998

Education

MD | Indiana University School of Medicine-Indianapolis. 1995

Awards

Buffalo Spree Top Doctor. 2020

Tweenty-first Annual Association of Asthma Educators Conference- Humanitarian/Outstanding Community Champion Award. 2019

Best Doctors of America. 2015 - 2016

Cardinal Glennon Foundation Ambassador Award- Care team Nominee. 2015 - 2016

Cardinal Glennon Foundation Ambassador Award- Individual Nominee. 2013

The Kayla award- Gateway Chapter, Cystic Fibrosis Foundation, Awarded to a new volunteer making a significant impact. 2012

SSM Saint Luke's Faithful Healer Award- Nominee. 2012

Best Teacher Award, pediatric Sub-specialty, Department of Pediatrics- Nominee. 2012

Publications

Journal Articles

Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines.

Schwarzenberg SJ, Hempstead SE, McDonald CM, Powers SW, Wooldridge J, Blair S, Freedman S, Harrington E, Murphy PJ, Palmer L, Schrader AE, Shiel K, Sullivan J, Wallentine M, Marshall BC, Leonard AR

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2016 November 15 (6):724-735. Epub 09/03/2016.

Improvements in Cystic Fibrosis Quarterly Visits, Lung Function Tests, and Respiratory Cultures.

Wooldridge JL, Mason S, Brusatti J, Albers GM, Noyes BE

Pediatrics.. 2015 December 136 (6):e1611-6. Epub 11/16/2015.

Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients.

Wooldridge JL, Szczesniak RD, Fenchel MC, Elder DA

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2015 November 14 (6):792-7. Epub 03/06/2015.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP, ,

The New England journal of medicine.. 2015 July 16373 (3):220-31. Epub 05/17/2015.

Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial.

Powers SW, Stark LJ, Chamberlin LA, Filigno SS, Sullivan SM, Lemanek KL, Butcher JL, Driscoll KA, Daines CL, Brody AS, Schindler T, Konstan MW, McCoy KS, Nasr SZ, Castile RG, Acton JD, Wooldridge JL, Ksenich RA, Szczesniak RD, Rausch JR, Stallings VA, Zemel BS, Clancy JP

JAMA pediatrics.. 2015 May 169 (5):e150636. Epub 05/04/2015.

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.

Tiddens HA, De Boeck K, Clancy JP, Fayon M, H G M A, Bresnik M, Derchak A, Lewis SA, Oermann CM,

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2015 January 14 (1):111-9. Epub 08/01/2014.

Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis.

Wooldridge JL, Schaeffer D, Jacobs D, Thieroff-Ekerdt R

Journal of pediatric gastroenterology and nutrition.. 2014 November 59 (5):612-5. Epub 1900 01 01.

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

Assael BM, Pressler T, Bilton D, Fayon M, Fischer R, Chiron R, LaRosa M, Knoop C, McElvaney N, Lewis SA, Bresnik M, Montgomery AB, Oermann CM,

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2013 March 12 (2):130-40. Epub 09/15/2012.

Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.

Wainwright CE, Quittner AL, Geller DE, Nakamura C, Wooldridge JL, Gibson RL, Lewis S, Montgomery AB

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2011 July 10 (4):234-42. Epub 03/26/2011.

Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.

Accurso FJ, Moss RB, Wilmott RW, Anbar RD, Schaberg AE, Durham TA, Ramsey BW,

American journal of respiratory and critical care medicine.. 2011 March 1183 (5):627-34. Epub 12/17/2010.

Using quality improvement science to implement a multidisciplinary behavioral intervention targeting pediatric inpatient airway clearance.

Ernst MM, Wooldridge JL, Conway E, Dressman K, Weiland J, Tucker K, Seid M

Journal of pediatric psychology.. 2010 35 (1):14-24. Epub 04/14/2009.

We can handle this: parents' use of religion in the first year following their child's diagnosis with cystic fibrosis.

Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M

Journal of health care chaplaincy.. 2010 16 (3-4):95-108. Epub 1900 01 01.

Parents' religious coping styles in the first year after their child's cystic fibrosis diagnosis.

Grossoehme DH, Ragsdale J, Cotton S, Wooldridge JL, Grimes L, Seid M

Journal of health care chaplaincy.. 2010 16 (3-4):109-22. Epub 1900 01 01.

EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.

Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2009 December 8 (6):405-17. Epub 08/15/2009.

Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.

Elder DA, Wooldridge JL, Dolan LM, D'Alessio DA

The Journal of pediatrics.. 2007 December 151 (6):653-8. Epub 09/17/2007.

NO pathway in CF and non-CF children.

Wooldridge JL, Deutsch GH, Sontag MK, Osberg I, Chase DR, Silkoff PE, Wagener JS, Abman SH, Accurso FJ

Pediatric pulmonology.. 2004 April 37 (4):338-50. Epub 1900 01 01.

Diaphragmatic hernia simulating a left pleural effusion.

Wooldridge JL, Partrick DA, Bensard DD, Deterding RR

Pediatrics.. 2003 December 112 (6 Pt 1):e487. Epub 1900 01 01.

Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.

Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, Whitsett JA

The Journal of biological chemistry.. 2003 February 28278 (9):7674-82. Epub 12/12/2002.

Books

Disorders of the Repiratory Tract in Children (Eighth Edition) (2012)

Chapter: Environmental Exposures in The Normal Host

Authors: Knutsen AP, Temprano J, Wooldridge JL, Bhatla D, Slavin RG

Publisher: Philadelphia, Saunders 2012

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.